FDA.reportPublic FDA data

Anthrasil 60 UNT Injection

RxCUI
1722407
RxNorm name
Anthrasil 60 UNT Injection
Display name
Anthrasil 60 UNT Injection
Full name
Anthrasil 60 UNT Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125562AnthrasilAnthrax Immune Globulin Intravenous (Human)351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
97cc9a89-6fe0-424e-82d1-0cf9d19444dbAnthrasil 60 UNT Injection [PSN] · anthrax immune globulin, human 60 UNT Injection [Anthrasil] [SBD] · Anthrasil 60 UNT Injection [SY]34These highlights do not include all the information needed to use ANTHRASIL ™ safely and effectively. See full prescribing information for ANTHRASIL. ANTHRASIL [Anthrax Immune Globulin Intravenous (Human)], sterile solution for infusion Initial U.S. Approval: March 24, 201520251216